Amino Acid Metabolism Practice Questions

Q: Which of the following is NOT true regarding Hanup disease?

Mostly asymptomatic. **Hartnup disease** is an autosomal recessive metabolic disorder caused by a mutation in the **SLC6A19 gene**, which encodes a neutral amino acid transporter in the proximal renal tubules and intestinal mucosa. This leads to the malabsorption and excessive urinary excretion of neutral amino acids, most notably **Tryptophan**. ### Why "Mostly Asymptomatic" is the Correct Answer (The Paradox) Despite the significant biochemical abnormality (aminoaciduria), the vast majority of individuals with Hartnup disease remain **clinically asymptomatic**. Symptoms typically only manifest during periods of nutritional deficiency (low protein intake) or increased metabolic demand. Therefore, stating it is "not true" that the disease is mostly asymptomatic is incorrect; it is, in fact, the most common clinical presentation. ### Explanation of Other Options * **Photosensitivity (A):** Tryptophan is a precursor for **Niacin (Vitamin B3)**. Deficiency leads to pellagra-like symptoms, including a red, scaly rash on sun-exposed areas (Casal’s necklace). * **Mental Retardation (B) & Developmental Delay (C):** While less common than skin symptoms, severe or untreated niacin deficiency during critical growth periods can lead to neurological impairment, including intellectual disability, cerebellar ataxia, and delayed milestones. ### High-Yield Clinical Pearls for NEET-PG * **The "3 Ds":** Hartnup disease mimics Pellagra (Dermatitis, Diarrhea, Dementia). * **Biochemical Marker:** High levels of **Indican** in the urine (due to bacterial degradation of unabsorbed tryptophan in the gut). * **Diagnosis:** Paper chromatography of urine showing a characteristic pattern of neutral amino acids. * **Treatment:** High-protein diet and **Nicotinamide** supplementation.

Q: Glycine is used in the synthesis of which of the following?

Purines. ### Explanation **Correct Answer: D. Purines** **1. Why Purines is Correct:** Glycine is a non-essential amino acid that serves as a vital precursor for several specialized products. In the synthesis of **purine nucleotides** (Adenine and Guanine), glycine provides three specific atoms: **C4, C5, and N7**. It is incorporated as a whole unit into the purine ring during the second step of the pathway. **2. Why Other Options are Incorrect:** * **A. Nitric oxide:** This potent vasodilator is synthesized from the amino acid **Arginine** by the enzyme Nitric Oxide Synthase (NOS). * **B. Catecholamines:** Dopamine, Norepinephrine, and Epinephrine are synthesized from **Tyrosine** (which is derived from Phenylalanine). * **C. Melanin:** This pigment is also synthesized from **Tyrosine** via the action of the enzyme Tyrosinase. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** To master glycine metabolism, remember the mnemonic **"G-H-P-C-B"** for its synthetic products: * **G**lutathione (Glycine + Glutamate + Cysteine) * **H**eme (Glycine + Succinyl CoA are the substrates for the rate-limiting enzyme ALA Synthase) * **P**urines (C4, C5, N7) * **C**reatine (Glycine + Arginine + SAM) * **B**ile Salts (Glycine conjugates with bile acids to form Glycocholate) **Key Exam Fact:** Glycine is the simplest amino acid (achiral) and acts as an **inhibitory neurotransmitter** in the spinal cord. Deficiency in the glycine cleavage system leads to **Non-ketotic Hyperglycinemia**, characterized by severe neurological distress.

Q: Succinyl CoA is formed by the catabolism of which of the following amino acids?

All of the above. **Explanation:** The conversion of specific amino acids into **Succinyl CoA**, a key intermediate of the TCA cycle, is a high-yield concept in biochemistry. Amino acids that enter the TCA cycle via Succinyl CoA are primarily the **glucogenic** branched-chain amino acids and sulfur-containing amino acids. **Why the correct answer is "All of the above":** The catabolism of **Valine, Isoleucine, Methionine, and Threonine** (often remembered by the mnemonic **VOMIT**) follows a common final pathway: 1. These amino acids are metabolized to **Propionyl CoA**. 2. Propionyl CoA is converted to **Methylmalonyl CoA** by *Propionyl CoA carboxylase* (requires Biotin/B7). 3. Methylmalonyl CoA is converted to **Succinyl CoA** by *Methylmalonyl CoA mutase* (requires Vitamin B12). * **Valine (Option A):** A purely glucogenic branched-chain amino acid (BCAA) that yields Propionyl CoA. * **Isoleucine (Option B):** Both glucogenic and ketogenic; it yields both Acetyl CoA and Propionyl CoA (which becomes Succinyl CoA). * **Methionine (Option C):** A sulfur-containing amino acid that enters the pathway via the formation of S-adenosylmethionine (SAM) and homocysteine, eventually yielding Propionyl CoA. **Clinical Pearls for NEET-PG:** * **Vitamin B12 Deficiency:** Leads to the accumulation of **Methylmalonic acid (MMA)** because the mutase enzyme cannot convert it to Succinyl CoA. This is a specific diagnostic marker for B12 deficiency, distinguishing it from Folate deficiency. * **Maple Syrup Urine Disease (MSUD):** Caused by a deficiency in the *Branched-chain alpha-keto acid dehydrogenase* complex, affecting the initial metabolism of Valine, Leucine, and Isoleucine. * **Propionic Acidemia:** Results from a deficiency of *Propionyl CoA carboxylase*, leading to metabolic acidosis and developmental delays.

Q: The FeCl3 test for urine in maple syrup urine disease gives which color?

Blue. **Explanation:** The **Ferric Chloride (FeCl₃) test** is a classic biochemical screening tool used to detect specific metabolites (usually phenols, enols, or keto-acids) in the urine. **1. Why Blue is Correct:** In **Maple Syrup Urine Disease (MSUD)**, there is a deficiency of the **Branched-Chain Alpha-Keto Acid Dehydrogenase (BCKAD)** complex. This leads to the accumulation of branched-chain amino acids (Leucine, Isoleucine, Valine) and their corresponding **alpha-keto acids**. Specifically, the presence of **alpha-ketoisovaleric acid** reacts with ferric chloride to produce a characteristic **navy blue** or bluish-gray color. **2. Analysis of Incorrect Options:** * **Green (Option A):** This is the classic result for **Phenylketonuria (PKU)** due to the presence of phenylpyruvic acid. It is a very high-yield distinction for NEET-PG. * **Black (Option C):** A "transient blue-green" turning into a **persistent black** color is seen in **Alkaptonuria** (due to homogentisic acid). * **Red/Purple (Option D):** A purple or Bordeaux-red color is seen in **Salicylate poisoning** or the presence of **Acetoacetate** (Ketone bodies). **3. High-Yield Clinical Pearls for MSUD:** * **Defective Enzyme:** BCKAD (requires Thiamine/B1 as a cofactor). * **Odor:** Urine smells like burnt sugar or maple syrup due to **S-isoleucine**. * **Diagnosis:** Elevated levels of Leucine, Isoleucine, and Valine in plasma; presence of **Alloisoleucine** (pathognomonic). * **Management:** Dietary restriction of BCAA and, in some cases, high-dose Thiamine supplementation.

Q: Which of the following is a dietary essential amino acid?

Methionine. **Explanation:** The classification of amino acids based on dietary requirements is a high-yield topic for NEET-PG. Amino acids are categorized as **Essential** (must be supplied in the diet because the body cannot synthesize them) or **Non-essential** (can be synthesized endogenously). **Why Methionine is Correct:** Methionine is one of the **10 essential amino acids**. A common mnemonic to remember these is **"PVT TIM HALL"** (Phenylalanine, Valine, Threonine, Tryptophan, Isoleucine, **Methionine**, Histidine, Arginine, Leucine, Lysine). Methionine is a sulfur-containing amino acid and serves as the precursor for S-adenosylmethionine (SAM), the body's primary methyl donor. **Analysis of Incorrect Options:** * **Cysteine:** This is a non-essential, sulfur-containing amino acid. It is considered "semi-essential" because its synthesis depends on the availability of Methionine (the essential precursor). * **Arginine:** While included in the "PVT TIM HALL" mnemonic, Arginine is technically **semi-essential** (or conditionally essential). The body can synthesize it in the urea cycle, but the rate is insufficient during periods of rapid growth or illness. In the context of this question, Methionine is the "more" essential/absolute requirement. * **Selenocysteine:** Known as the 21st amino acid, it is synthesized on its tRNA from Serine; it is not a dietary essential requirement. **High-Yield Clinical Pearls for NEET-PG:** * **Ketogenic vs. Glucogenic:** Methionine is purely **glucogenic**. * **First Amino Acid:** Methionine is the initiating amino acid in eukaryotic protein synthesis (coded by the start codon **AUG**). * **Homocystinuria:** A deficiency in Cystathionine beta-synthase leads to an accumulation of Homocysteine and Methionine, presenting with ectopia lentis, intellectual disability, and thromboembolism. * **Purely Ketogenic Amino Acids:** Leucine and Lysine (The "L"s).

Q: What is the major source of ammonia in the kidney?

Glutamine. **Explanation:** The kidney plays a vital role in acid-base balance by excreting hydrogen ions in the form of ammonium ($NH_4^+$). The major source of this ammonia is the amino acid **Glutamine**. **Why Glutamine is correct:** Approximately 60–80% of renal ammonia is derived from the metabolism of Glutamine, primarily in the cells of the **Proximal Convoluted Tubule (PCT)**. The process involves two key steps: 1. **Glutaminase** enzyme converts Glutamine into Glutamate, releasing one $NH_3$ molecule. 2. **Glutamate Dehydrogenase** then converts Glutamate into alpha-ketoglutarate, releasing a second $NH_3$ molecule. The resulting ammonia ($NH_3$) diffuses into the tubular lumen, where it buffers $H^+$ to form $NH_4^+$, which is then excreted. **Why other options are incorrect:** * **Glutamate:** While Glutamate is an intermediate in the production of ammonia, it is secondary to Glutamine. Glutamine is the preferred "carrier" of nitrogen from the liver and muscles to the kidneys. * **Alpha-ketoglutarate:** This is the carbon skeleton "end-product" of the deamination process. It is metabolized to produce bicarbonate ($HCO_3^-$), which is reabsorbed into the blood to further buffer systemic acidity. * **Alanine:** Alanine is the primary nitrogen carrier for the liver (Glucose-Alanine cycle) rather than the kidney. **High-Yield Clinical Pearls for NEET-PG:** * **Site of production:** Ammonia production occurs predominantly in the **PCT**. * **Regulation:** In states of **chronic metabolic acidosis**, renal ammonia production can increase significantly (up to 10-fold) to enhance $H^+$ excretion. * **Diffusion Trapping:** $NH_3$ is lipid-soluble and diffuses easily; once it combines with $H^+$ to form $NH_4^+$, it becomes water-soluble and "trapped" in the lumen for excretion.

Q: What is the most appropriate treatment for Homocystinuria?

Vitamin B6. **Explanation:** **Homocystinuria** is most commonly caused by a deficiency of the enzyme **Cystathionine β-synthase (CBS)**. This enzyme facilitates the conversion of homocysteine to cystathionine. Crucially, CBS requires **Pyridoxine (Vitamin B6)** as a mandatory cofactor. 1. **Why Vitamin B6 is correct:** Approximately 50% of patients with Homocystinuria are "B6-responsive." High doses of Vitamin B6 can stabilize the mutated CBS enzyme, enhancing its residual activity and effectively lowering toxic homocysteine levels. It is considered the first-line pharmacological intervention. 2. **Why other options are incorrect:** * **Betaine (A):** While used as an adjunct treatment, it acts by providing methyl groups to convert homocysteine back to methionine (remethylation pathway). It is typically reserved for B6-non-responsive patients. * **Folic acid (B):** Folate and Vitamin B12 are essential cofactors for the remethylation of homocysteine, but they are supportive therapies rather than the primary corrective treatment for the classic CBS deficiency. * **Vitamin C (C):** Has no direct role in the metabolic pathway of sulfur-containing amino acids or the treatment of Homocystinuria. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Triad:** Intellectual disability, Ectopia lentis (downward dislocation of lens), and Thromboembolic events (major cause of mortality). * **Marfanoid Habitus:** Patients often present with long limbs and chest deformities, but unlike Marfan syndrome (upward lens dislocation), Homocystinuria features downward lens dislocation and autosomal recessive inheritance. * **Diagnosis:** Elevated homocysteine in urine (Cyanide-nitroprusside test) and blood. * **Dietary Management:** Low methionine diet and Cysteine supplementation (as Cysteine becomes an essential amino acid).

Q: Which amino acid undergoes the most significant hepatic oxidative deamination, which is used for urea synthesis?

Glutamate. **Explanation:** The correct answer is **Glutamate**. In amino acid metabolism, most peripheral amino acids first undergo **transamination**, where their $\alpha$-amino group is transferred to $\alpha$-ketoglutarate to form **Glutamate**. Glutamate then serves as the "collection center" for amino groups. It undergoes **oxidative deamination** in the mitochondria of hepatocytes, catalyzed by the enzyme **Glutamate Dehydrogenase (GDH)**. This reaction releases free ammonia ($NH_3$), which enters the **Urea Cycle** to be detoxified and excreted. This is the only reaction in humans that can rapidly release nitrogen from amino acids as free ammonia. **Why other options are incorrect:** * **Glutamine:** While it is the primary non-toxic transporter of ammonia in the blood, it undergoes *hydrolysis* by glutaminase to form glutamate, rather than direct oxidative deamination for the bulk of urea synthesis. * **Aspartate:** It provides the second nitrogen atom for the urea cycle by condensing with citrulline, but it does so via *transamination*, not oxidative deamination. * **Arginine:** It is an intermediate of the urea cycle itself. It is cleaved by arginase to produce urea and ornithine, but it does not undergo oxidative deamination to initiate the process. **Clinical Pearls for NEET-PG:** * **Glutamate Dehydrogenase (GDH)** is unique because it can use either **NAD+** (for catabolism/deamination) or **NADP+** (for anabolism/amination) as a coenzyme. * GDH is allosterically inhibited by **GTP/ATP** and activated by **ADP/GDP**, linking nitrogen metabolism to the energy status of the cell. * **Transdeamination:** The combined action of aminotransferases and GDH is the most efficient pathway for nitrogen disposal.

Q: Which enzyme is involved in the regulation of the urea cycle?

Carbamoyl phosphate synthetase. **Explanation:** The urea cycle is the primary mechanism for disposing of nitrogenous waste in humans. The correct answer is **Carbamoyl Phosphate Synthetase I (CPS-I)**, as it serves as the **rate-limiting and committed step** of the cycle. 1. **Why CPS-I is correct:** Located in the mitochondria, CPS-I catalyzes the condensation of $NH_4^+$ and $CO_2$ to form carbamoyl phosphate. It is uniquely regulated by its obligatory allosteric activator, **N-acetylglutamate (NAG)**. Without NAG, CPS-I is inactive. NAG levels rise when arginine levels are high, signaling an abundance of amino acids and the need for increased urea production. 2. **Why other options are incorrect:** * **Ornithine transcarbamoylase (OTC):** While it is the most common site of genetic urea cycle defects (X-linked), it is not the primary regulatory enzyme. * **Argininosuccinase (Argininosuccinate Lyase):** This enzyme cleaves argininosuccinate into arginine and fumarate. It is a reversible step and does not control the flux of the cycle. * **Arginase:** This is the final enzyme that releases urea. While it is essential for completing the cycle, it does not act as the metabolic "pacemaker." **High-Yield Clinical Pearls for NEET-PG:** * **Location:** The urea cycle occurs in both the **mitochondria** (first two steps) and the **cytosol** (remaining steps). * **CPS-I vs. CPS-II:** Do not confuse them. CPS-I is for the **U**rea cycle (**M**itochondrial), while CPS-II is for **P**yrimidine synthesis (**C**ytosolic). * **Hyperammonemia:** Deficiency in any urea cycle enzyme leads to ammonia toxicity. CPS-I deficiency presents with severe hyperammonemia but **no** orotic aciduria (unlike OTC deficiency).

Question 1

Which of the following is NOT true regarding Hanup disease?

Accepted Answer

Mostly asymptomatic

Answer

Associated with photosensitivity

Answer

Mental retardation

Answer

Developmental delay

Question 2

Glycine is used in the synthesis of which of the following?

Accepted Answer

Purines

Answer

Nitric oxide

Answer

Catecholamines

Answer

Melanin

Question 3

Succinyl CoA is formed by the catabolism of which of the following amino acids?

Accepted Answer

All of the above

Answer

Valine

Answer

Isoleucine

Answer

Methionine

Question 4

The FeCl3 test for urine in maple syrup urine disease gives which color?

Accepted Answer

Blue

Answer

Green

Answer

Black

Answer

Red

Question 5

Which of the following is a dietary essential amino acid?

Accepted Answer

Methionine

Answer

Cysteine

Answer

Arginine

Answer

Selenocysteine

Question 6

What is the major source of ammonia in the kidney?

Accepted Answer

Glutamine

Answer

Glutamate

Answer

alpha-ketoglutarate

Answer

Alanine

Question 7

What is the most appropriate treatment for Homocystinuria?

Accepted Answer

Vitamin B6

Answer

Betaine

Answer

Folic acid

Answer

Vitamin C

Question 8

Which amino acid undergoes the most significant hepatic oxidative deamination, which is used for urea synthesis?

Accepted Answer

Glutamate

Answer

Glutamine

Answer

Aspartate

Answer

Arginine

Question 9

Which amino acids are absorbed in enterocytes through the Meiser cycle?

Accepted Answer

Neutral amino acids

Answer

Dibasic amino acids

Answer

Basic amino acids

Answer

Dicarboxylic amino acids

Question 10

Which enzyme is involved in the regulation of the urea cycle?

Accepted Answer

Carbamoyl phosphate synthetase

Answer

Ornithine transcarbamoylase

Answer

Argininosuccinase

Answer

Arginase

Amino Acid Metabolism — MCQs

Amino Acid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?